K-ras mutation, HPV infection and smoking or alcohol abuse positively correlate with esophageal squamous carcinoma

被引:30
作者
Lyronis, Ioannis D. [1 ]
Baritaki, Stavroula [1 ]
Bizakis, Ioannis [2 ]
Krambovitis, Elias [3 ]
Spandidos, Demetrios A. [1 ]
机构
[1] Univ Crete, Sch Med, Dept Virol, Iraklion 71110, Greece
[2] Univ Hosp Crete, Dept Otolaryngol, Iraklion 71201, Greece
[3] Univ Thessaly, Dept Vet Med, Kardhitsa, Greece
关键词
esophageal squamous cell carcinoma; human papilloma virus; B-raf; K-ras; N-ras;
D O I
10.1007/s12253-008-9032-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Ras/Raf/MEK/ERK (MAPK) signal transduction cascade is an important mediator of a number of cellular fates including growth, survival and apoptosis. The aim of this study was to determine the incidence of B-raf, Kirsten-ras (K-ras) and Neuroblastoma-ras (N-ras) gene mutations in esophageal squamous cell carcinoma (ESCC) in the Greek population. DNA was extracted from 30 ESCC and 32 normal esophageal specimens and screened for V600E B-raf, and K-ras/N-ras codon 12 mutations, by PCR-RFLP based analysis. Among the genes tested, only the heterozygous K-ras mutation was detected in 5 out of the 30 ESCC specimens (16%), whereas no mutation was found in the normal esophageal tissue (P < 0.022). The normal samples were screened negative for N-ras and V600E B-raf mutations. The increased risk of esophageal cancer was correlated with tobacco use (OR=3.5, P < 0.023) and alcohol abuse (OR=7.22, P < 0.001), accompanied with the high incidence of the k-ras codon 12 mutation (22%, OR=1.77 and 21%, OR=1.52), respectively. A similar positive association was seen in human papilloma virus (HPV)-infected patients (OR=5.66, P < 0.003). Our overall findings demonstrate that the mutational activation of the K-ras gene, HPV infection and tobacco or alcohol abuse, can be considered independently or in combination as high risk factors for ESCC development.
引用
收藏
页码:267 / 273
页数:7
相关论文
共 32 条
[1]   Activation of c-K-ras mutations in human gastrointestinal tumors [J].
Arber, N ;
Shapira, I ;
Ratan, J ;
Stern, B ;
Hibshoosh, H ;
Moshkowitz, M ;
Gammon, M ;
Fabian, I ;
Halpern, Z .
GASTROENTEROLOGY, 2000, 118 (06) :1045-1050
[2]  
Arora Sonia, 2001, Pathology and Oncology Research, V7, P203
[3]   Smoking cessation and the risk of oesophageal cancer: An overview of published studies [J].
Bosetti, Cristina ;
Gallus, Silvano ;
Garavello, Werner ;
La Vecchia, Carlo .
ORAL ONCOLOGY, 2006, 42 (10) :957-964
[4]  
Chetty R, 1999, Pathol Oncol Res, V5, P193, DOI 10.1053/paor.1999.0196
[5]   BRAF mutation in papillary thyroid carcinoma [J].
Cohen, J ;
Xing, MZ ;
Mambo, E ;
Guo, ZM ;
Wu, GG ;
Trink, B ;
Beller, U ;
Westra, WH ;
Ladenson, PW ;
Sidransky, D .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (08) :625-627
[6]   Mutations of the BRAF gene in human cancer [J].
Davies, H ;
Bignell, GR ;
Cox, C ;
Stephens, P ;
Edkins, S ;
Clegg, S ;
Teague, J ;
Woffendin, H ;
Garnett, MJ ;
Bottomley, W ;
Davis, N ;
Dicks, N ;
Ewing, R ;
Floyd, Y ;
Gray, K ;
Hall, S ;
Hawes, R ;
Hughes, J ;
Kosmidou, V ;
Menzies, A ;
Mould, C ;
Parker, A ;
Stevens, C ;
Watt, S ;
Hooper, S ;
Wilson, R ;
Jayatilake, H ;
Gusterson, BA ;
Cooper, C ;
Shipley, J ;
Hargrave, D ;
Pritchard-Jones, K ;
Maitland, N ;
Chenevix-Trench, G ;
Riggins, GJ ;
Bigner, DD ;
Palmieri, G ;
Cossu, A ;
Flanagan, A ;
Nicholson, A ;
Ho, JWC ;
Leung, SY ;
Yuen, ST ;
Weber, BL ;
Siegler, HF ;
Darrow, TL ;
Paterson, H ;
Marais, R ;
Marshall, CJ ;
Wooster, R .
NATURE, 2002, 417 (6892) :949-954
[7]  
Ellis A, 1994, Eur J Cancer B Oral Oncol, V30B, P102, DOI 10.1016/0964-1955(94)90061-2
[8]   Medical progress - Esophageal cancer [J].
Enzinger, PC ;
Mayer, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (23) :2241-2252
[9]  
FENOGLIOPREISER CM, 1999, GASTROINTESTINAL PAT, P102
[10]   Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas [J].
Fransén, K ;
Klintenäs, M ;
Österström, A ;
Dimberg, J ;
Monstein, HJ ;
Söderkvist, P .
CARCINOGENESIS, 2004, 25 (04) :527-533